Tumour vascular targeting.

Neri D; Bicknell R

doi:10.1038/nrc1627

Back

Journal article

Tumour vascular targeting.

Neri D Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zürich, Wolfgang-Pauli-Strasse 10, CH-8093 Zürich, Switzerland. dario.neri@pharma.ethz.ch
Bicknell R

2005-06-02

Published in:

Nature reviews. Cancer. - 2005

Neovascularization, Pathologic

English It is now accepted that the growth of solid tumours is dependent on their capacity to acquire a blood supply, and much effort has been directed towards the development of agents (known as anti-angiogenics) that disrupt this process. More recently, it has become apparent that targeted destruction of the established tumour vasculature is another avenue for exciting therapeutic opportunities. In this article, we present evidence that vascular targeting is an effective antitumour strategy in animal models, describe strategies for identifying putative tumour vascular targets and discuss future prospects for vascular targeting in the clinic.

Language